Mario Gabelli Nevro Corp Transaction History

Gamco Investors, Inc. Et Al

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 01, 2019	SELL	$61.52 - $91.1 $799,760 - $1.18 Million	-13,000 Closed	0 $0
Q2 2019 Aug 02, 2019	SELL	$58.04 - $66.99 $359,848 - $415,337	-6,200 Reduced 32.29%	13,000 $843,000
Q1 2019 May 02, 2019	SELL	$35.52 - $62.62 $35,520 - $62,620	-1,000 Reduced 4.95%	19,200 $1.2 Million
Q4 2018 Jan 30, 2019	BUY	$35.43 - $56.29 $141,720 - $225,160	4,000 Added 24.69%	20,200 $786,000
Q3 2018 Nov 02, 2018	BUY	$44.22 - $75.47 $495,264 - $845,264	11,200 Added 224.0%	16,200 $923,000

Q2 2018 Aug 10, 2018	SELL	$72.38 - $92.5 $72,380 - $92,500	-1,000 Reduced 16.67%	5,000 $399,000
Q4 2017 Feb 02, 2018	BUY	$65.94 - $93.31 $395,640 - $559,860	6,000	6,000 $414,000

173

37.4M

80.4K

898K

Ticker NVRO
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 35,387,800
Market Cap $295M
Description
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It...

Get notified when there are updates to the investment portfolio of Gamco Investors, Inc. Et Al, based on Form 13F filings with the SEC.

Stay updated on Gamco Investors, Inc. Et Al and Mario Gabelli with notifications on news.